Overall, the lack of exposure effects on the clinical inaton was reassuring. The findings for self-reported symptoms raise some concern, as does the finding of low performance for those reporting prior poisoning. Although this was a relatively large study based on a well-defined target population, the workers we studied may not be representative of all exposed workers, and caution should be exercised in generalizing our results. Key wordr. chlorpyrifos, neurotoxicity, organophosphates. Environ Health Perspect 108:293-300 (2000) . [ Online 18 February 2000] htp://ehp: netl.nie h .nih.rov/docs/2000/108p293-300steenland/abstratmIn l Chlorpyrifos ( O0-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate) is an organophosphate pesticide used in both agricultural and residential pest control. It exhibits moderate acute toxicity, readily inhibiting plasma cholinesterase at low doses and inhibiting red blood cell cholinesterase at high doses (1) . Like all organophosphates, chlorpyrifos can cause acute poisoning; well-known symptoms include miosis, increased urination, diarrhea, diaphoresis, lacrimation, and salivation (2) . Chlorpyrifos was first marketed in 1965. Its use has increased rapidly, in part due to the banning of chlordane for termite applications in 1988. The principal manufacturer of chlorpyrifos (Dow Elanco, Indianapolis, IN) has estimated that chlorpyrifos-containing products are applied in and around American homes more than 20 million times a year (3) . In a survey of a random sample of U.S. adults (n = 929) conducted in the late 1980s and early 1990s, Hill et al. (4) estimated that detectable levels of a metabolite of chlopyrifos (3, 5, 6 -trichloro-2-pyridinol; TCP) are present in the urine of 82% of U.S. adults, with a mean level of 4.5 pg/L. TCP is largely specific for chlorpyrifos, although two other less common pesticides, chlorpyrifos-methyl and triclopyr, can also be metabolized to TCP. Agricultural use of chlorpyrifos is also common, accounting for about two-thirds of chlorpyrifos sales (5) .
U.S. Environmental Protection Agency (EPA) investigators summarized chlorpyrifos poisoning data based on reports from poison control centers and concluded that "chlorpyrifos is one of the leading causes of acute insecticide poisoning incidents in the United States (6) ." U.S. poison control center data for 1993-1994 (6) showed approximately 4,000-5,000 reported cases of unintentional chlorpyrifos exposures per year, with approximately half of these exposures in adults.
Approximately 50% of the cases were followed in more detail, and approximately half of these were judged to have symptoms consistent with clinical poisoning (85% with minor symptoms and 15% with moderate or severe symptoms). A subsequent analysis of this same database (3) reported similar numbers. The large number of reported cases is consistent with the widespread use of chlorpyrifos; the data do not suggest that chlorpyrifos is disproportionately responsible to acute poisonings as compared with other organophosphates.
The potential of chlorpyrifos to cause chronic neurotoxic effects, either because of low level chronic exposure or as sequelae to acute poisoning, is controversial. Based on animal data, chlorpyrifos can cause a mild delayed peripheral neuropathy subsequent to inhibition of neurotoxic esterase (NTE), but only at lethal levels [above the median lethal dose (LD50)] after prophylaxis against cholinergic toxicity (1) . There are few epidemiologic data on the subject. There are two case reports of delayed peripheral neuropathy in humans following ingestion of a nearly lethal dose (7, 8) . Steenland et al. (9) found slower peroneal nerve conduction in 10 men previously poisoned by chlorpyrifos as compared to 90 nonpoisoned subjects; they also observed decreased performance in finger vibrotactile sensitivity and worse selfreported emotional moods in 17 men poisoned by a mixture of organophosphates, including chlorpyrifos. However, no differences were seen on a large number of other neurologic tests.
There are three limited studies regarding neurologic effects attributable to chronic lowlevel exposure. Ames et al. (10) conducted a cross-sectional telephone survey of 68 California pet handlers who used chlorpyrifos to treat fleas. These workers reported significantly higher incidences of blurred vision, flushing of skin, and decreased urination, as compared to nonexposed subjects. Two of these symptoms are consistent with chronic poisoning, but the finding for decreased urination is contradictory. Burns et al. (11) studied 496 men potentially exposed to chlorpyrifos during the manufacturing process and 911 matched nonexposed controls. Exposed subjects did not differ from controls for most medical conditions, but they did report significantly more general illdefined conditions (dizziness, fever, malaise, fatigue), which were more common in subjects with a history of cholinesterase inhibition. This study (11) was limited because the authors relied on medical data obtained at work from subjects who were self-referred and by the lack of data on neurologic outcomes after exposure. Kaplan et al. (12) presented data on a case series of eight subjects who were reportedly exposed to chlorpyrifos and who subsequently exhibited a mild sensory neuropathy and some memory problems; the documentation of exposure in this study is weak.
In light of some suggestive evidence in the literature regarding chronic neurologic effects of exposure and the widespread use of chlorpyrifos in the United States, we conducted a cross-sectional study of neurologic function among current and former termiticide applicators who had used or were using chlorpyrifos; chlorpyrifos has been the main termiticide used in the United States since chlordane was banned in 1988.
Methods
Exposed population. The exposed population in our study was Neurologic tests. We conducted neurologic tests for both central and peripheral function; testers were blind to exposure status. All tests had been used previously in other epidemiologic studies (14, 15) .
Neurobehavioral Evaluation System. The Neurobehavioral Evaluation System (NES) is used primarily to measure cognitive functions (16 (24) .
Olfaction (cross-cultural smell identification test). Recent reviews have indicated possible effects of pesticides on the sense of smell (15, 25) . In the cross-cultural smell identification test, the participant must scratch and smell the 12 microencapsulated odors and choose the perceived odor from four choices (26) . The odors were originally prepared for the University of Pennsylvania Smell Identification Test (UPSIT) (26) . We analyzed either the number of odors (out of 12) correctly identified or the age-adjusted percentile of correctly identified smells.
Nerve conduction velocity. We measured nerve conduction velocity (time from stimulation to depolarization) and peak amplitude (the size of the maximal response of the compound action potential) by using surface electrodes in three nerves of dominant limbs (peroneal motor, sural, and ulnar sensory nerves) at 33.0°C for the lower limb and 32.0°C for the upper limb. Motor responses were orthodromic, whereas sensory responses were antidromic. We expected peripheral effects on nerve conduction in the lower limbs with longer nerves (peroneal motor, sural sensory); in some participants the sural response was difficult to measure and the ulnar (in the arm) served as a substitute.
Clinical examination. A brief (15 min) clinical neurologic examination was conducted on all participants by two neurologists; both neurologists were trained to ensure that their methods were comparable. The examination consisted of observation of pupils and eye movement, tremor, coordination, tone, strength, sensation, reflexes, station, and gait.
Analyses were restricted to those end points in which more than 10 participants were judged to be abnormal.
Questionnaire. We used a short 24-item self-administered questionnaire to determine neurologic symptoms in the last month (e.g., "in the past month have you experienced trouble remembering," "loss of muscle strength," "numbness or tingling in toes," "lack of coordination or loss of balance"). This is a modified form of the traditional Hogstedt symptom questionnaire (22'); each question has five possible ordered responses. Analyses considered either continuous data or dichotomized data (i.e., "not at all" vs. all higher categories combined), depending on the response variability.
Biologic samples: urine and buccal swabs. Applicators who had reported current exposure during a phone interview a few weeks before testing (n = 105) collected urine samples (first void) and brought them to the testing site. TCP, a metabolite largely specific to chlorpyrifos (half-life approximately 27 hr), was measured in the urine. We also measured TCP in samples from 52 nonexposed participants. We retained approximately 25 mL urine for analysis of TCP by gas chromatography by a commercial laboratory. The laboratory's limit of detection for TCP by gas chromatography is 2 ng/mL (28) . We also measured creatinine.
We obtained buccal cells to determine the genotype of participants with regard to paraoxonase, an enzyme that is instrumental in detoxifying chlorpyrifos (29, 30) . The gene for paraoxonase at amino acid 54 (chromosome 7) exhibits a polymorphism in humans. Individuals homozygous for methionine, representing about 15% of the population, are likely to exhibit lower serum concentrations of the enzyme (31, 32) and would be expected to be more susceptible to neurotoxicity due to chlorpyrifos oxon, the neurotoxic metabolite of chlorpyrifos. We obtained buccal swabs from all of the exposed subjects and from a sample of 55 nonexposed participants to ensure that the exposed and nonexposed subjects exhibited a similar distribution of the polymorphism.
We isolated DNA from buccal swabs using a commercially available kit (Epicentre Technologies, Madison, WI). We then amplified the paraoxonase gene from the DNA by polymerase chain reaction (PCR) using primers specific for sequences in the gene (33) . We assayed the amplified paraoxonase gene for differences in DNA sequence at position 54 using a colorometric method specific for each allele (34) .
Data analysis. In our data analysis we focused on comparing results of the neurologic tests of the exposed subjects versus the nonexposed subjects. We used linear regression for this purpose and adjusted for possible confounding variables. We used logistic regression for some outcomes that were dichotomous or polychotomous (e.g., all clinical examination outcomes, and some vision and symptom outcomes). We also used proportional odds models for some polychotomous outcomes, but these are not reported.
We checked demographic variables for potential confounding effects and inclusion in regression models. We constructed a basic model that included variables of a priori interest for most tests, i.e., age (continuous), race (white/nonwhite), and education (less than high school, high school, some college, and college graduate), as well as a variable for current smoking, which proved to be predictive for several tests. We did not adjust for sex; there were only six women in the study population, and we found no evidence of gender effects. For tests of peripheral neuropathy (e.g., nerve conduction, vibration sensitivity, tremor, sway, clinical examination), we also routinely included body mass index. We tested other variables, such as hours of sleep the night before, alcohol consumption the night before, current exposure to solvents, and coffee consumption the day of the tests, to explore possible confounding, but these variables were generally not predictive of outcome and were not included in the final models. In addition, we checked tests of peripheral neuropathy for the potential confounding effects of a history of diabetes (n = 12), carpal tunnel syndrome (n = 12), nerve disorder (n = 17), nerve injury (n = 16), or back disorder (n = 66); these variables in general did not act as confounders.
We tested whether the exposed group differed from both nonexposed groups combined for each outcome and for each control group separately. Results are reported for both control groups combined unless they differed by control groups; in this case, they are reported separately. After comparing the exposed subjects to the nonexposed subjects, we ran further models in which we compared a variety of exposed subgroups to the nonexposed group; these included a) workers currently applying termiticide in 1998 (n = 128), b) workers formerly applying termiticide (n = 63), c) workers with selfreported poisoning by chlorpyrifos (n = 8), and a) workers with a susceptible genotype (n = 18). Within the applicator group we also tested trends by duration of exposure to chlorpyrifos, chlordane, and other pesticides.
We also ran models, after restricting the data to those with TCP values (n = 157), in which we determined if higher TCP levels (reflecting recent exposure) were associated with the neurologic outcomes; log of TCP and TCP corrected for creatinine were also considered, but these generally did not improve the fit of the model to the data.
We assessed all linear regression models for model fit (R2) and checked residuals for normality; we made log transformations of outcome as needed to normalize residuals. There were a large number of comparisons. We made no formal statistical correction for multiple comparisons (e.g., Bonferroni), but we interpreted the overall results with a view toward consistency and biologic plausibility (35 We tested 106 "friend" controls who were identified by the applicators, and 83 North Carolina blue-collar state employees. Table 1 shows the demographic characteristics of the termiticide applicators and the nonexposed participants. Exposed and nonexposed participants were similar, but the exposed subjects had somewhat less education. We found no significant difference in education between applicators and both nonexposed groups combined (p = (4) .
There are few data on chlorpyrifos exposure levels in other occupationally exposed workers to compare with data on termiticide applicators. Brenner et al. (36) estimated that time-weighted averaged air levels based on personal samples range from 10 to 120 pg/m3 among chlorpyrifos-manufacturing workers. In work done as part of this study, Hines (37) reported a median full-shift air level of 14 pg/m3 chlorpyrifos for 16 termiticide operators (range 2-126). Fenske and Elkner (38) studied six chlopyrifos applicators and found a median air concentration of 10 pg/m3 (range 2-35) over a full shift. These data suggest that termiticide applicators and manufacturing workers may be similarly exposed, although most absorption is probably dermal and comparative air levels may not reflect comparative dermal exposure. In any case, the urinary TCP levels show that the termiticide workers we studied were exposed to levels two orders of magnitude above background, making them a reasonable population in which to study exposure effects.
By genotyping the paraoxonase gene in 184 termiticide applicators (7 samples could not be genotyped), we determined that 18 (10%) were homozygous for the gene which is responsible for potentially producing a low level of paraoxonase; these applicators might be expected to be more susceptible to the effects of chlorpyrifos. A sample of 52 nonexposed participants showed a similar proportion of homozygotes (9%).
Nerve conduction. There were no significant differences ( Clinical examination. The clinical examination results showed no significant differences between exposed and nonexposed subjects for abnormal upper extremity tremor (95 were abnormal with exposed and Table 2 nonexposed combined); abnormal toe, finger, wrist, ankle, or knee sensitivity to vibration (134, 54, 11, 66, and 43 were abnormal, respectively); abnormal sensation in response to a pinprick in the arm or leg (24 and 11 were abnormal, respectively); abnormal gastroc soleus reflex (16 were abnormal), or abnormal Romberg test (12 were abnormal). The majority of subjects had at least one abnormality (n = 208). Overall, the exposed subjects had a significantly lower probability of any abnormality than the nonexposed subjects (p = 0.006), a finding that was consistent for each individual nonexposed group. On the other hand, the average number of abnormalities (for each subject) did not differ significantly between the exposed and nonexposed groups (p = 0.44).
The TCP level was not a significant predictor of any clinical outcomes. The eight men who reported chlorpyrifos poisoning had decreased wrist sensitivity to vibration (p = 0.003) and decreased sensitivity to leg pinprick (p = 0.002). The 18 exposed men with the susceptible genotype had increased odds of a abnormal gastroc soleus reflex (p = 0.01) and an abnormal Romberg test (p = 0.04); the latter finding was not seen on the analogous computerized sway tests. Currently exposed applicators had borderline higher odds of an abnormal leg pinprick test (p = 0.08), whereas formerly exposed applicators had borderline higher odds of an abnormal gastroc soleus reflex.
Visuomotor tests: trails and pegboard. The exposed group did not perform as well as the nonexposed group in the pegboard test for the dominant hand (p = 0.07). This effect was apparent when the applicators were compared to state employee controls (p = 0.005) but not when applicators were compared to nonexposed friends (p = 0.43). Results Neurobehavioral tests. There were no significant differences between the exposed and nonexposed groups on most of the neurobehavioral tests (simple reaction time, symbol-digit, continuous performance, digit span, forward and backward, pattern memory, vocabulary). There was no significant difference in self-reported effort on these tests between the exposed and nonexposed groups. The J2 values for the exposed/nonexposed models were 5%, 34%, 7%, 12%, 16%, 13%, and 31%, respectively, for these tests. The level of TCP did not significantly predict performance on any of these tests except for the vocabulary test, for which subjects with more urinary TCP did significantly worse (p = 0.02). In results of these tests in exposed subjects, we found no significant effects of current versus former exposure; duration of use of chlorpyrifos, chlordane, or other pesticides; or presence of a susceptible genotype. Self-reported poisoning by chlorpyrifos was associated with decreases in performance on the continuous performance test (p = 0.0001) and on simple reaction time (p = 0.06).
Of the five components that constitute the mood scales, the exposed subjects reported significantly more fatigue and tension than the nonexposed subjects (p = 0.0002 and p = 0.01, respectively). The finding for fatigue was significant for the applicators versus each nonexposed group separately, whereas the finding for tension was significant for the applicators versus state employees (p = 0.007) but not versus nonexposed friends (p = 0.14). The test for anger (p = 0.07) was borderline significant (vs. state employee controls, p = 0.008). The test for depression was significant for exposed subjects versus nonexposed friends (p = 0.05) but not versus state employees (p = 0.55). The eight men who reported past chlorpyrifos poisoning reported significantly or borderline significantly more anger (p = 0.06), fatigue (p = 0.02), tension (p = 0.01), depression (p = 0.06), and confusion (p = 0.03). Those Symptom questionnaire. The exposed subjects reported significantly more symptoms than nonexposed subjects on 16 of the 24 questions about frequency of symptoms in the last month. The exposed subjects more often reported being tired, dizzy (2 items), confused, less able to remember (3 items), irritated, and less coordinated, and having a loss of strength in limbs (4 items), headaches, susceptibility to dizziness from chemicals, and less tolerance for alcohol. We found borderline significant findings (0.05 < p < 0.10) on reported increased depression, worse concentration, and numbness and tingling in toes. The I2 values for linear models were low, on the order of 0.05; in the logistic models, few variables other than exposure were predictive of outcome. Several of the symptoms were highly correlated with each other, particularly for three related questions on remembering; two questions about confusion and difficulty concentrating; and four questions on loss of strength in arms, hands, fingers, and legs (pairwise Spearman correlation coefficients 0.40-0.60). Previously exposed applicators were significantly different from the nonexposed subjects on 12 items, whereas currently exposed applicators had nine significant associations. The eight men reporting previous chlorpyrifos poisoning had 10 significant associations (tiredness, memory, irritability, dizziness, understanding written material, sleep problems, arm/hand/leg weakness, and lack of coordination) and 1 borderline significant one (heart palpitations). 
Discussion
This study is the first large study of clinical and subclinical neurologic effects of participants who have been exposed to chlorpyrifos. This study has a number of strengths, including a thorough evaluation of neurologic function at both the dinical and subdinical level, a well-defined exposed population, and a large sample size.
However, existing "objective" tests for neurologic effects may not be adequate to detect some effects caused by exposure. In our study, exposed subjects reported significantly more symptoms than nonexposed subjects, but relatively few significant differences were found when more quantitative tests were used.
The weaknesses of our study include possible selection biases. We were able to recruit only a minority of the exposed target population, primarily because we could not locate many subjects. However, we tested 69% of eligible applicators whom we contacted. The nature of any possible selection bias is not clear: workers more affected by chlorpyrifos may have preferentially participated; on the other hand, workers most affected by exposure may have left the workforce or been harder to find, and thus did not participate. One strength of our study is that it was population-based and had a defined target population; this tends to decrease selection biases.
We studied termiticide applicators because they are exposed primarily to chlorpyrifos rather than other pesticides. However, we found that termiticide applicators also had substantial exposure to other pesticides including chlordane, which preceded chlorpyrifos as the main pesticide used against termites. Nonetheless, in the analyses we found Volume 108, Number 4, April 2000 * Environmental Health Perspectives that exposure to chlordane or other pesticides was not, in general, associated with effects and therefore was unlikely to confound the analysis of chlorpyrifos.
Our study population was rather young-90% of the applicators were under 50 years of age. If chlorpyrifos causes delayed neurotoxic effects that become apparent only with age, we would have missed such effects. Table 3 provides a summary of all results. We found few significant differences between exposed and nonexposed subjects on the clinical examination, with the exception of 2 (out of 10) tests that indicated increased abnormality for the 8 men who reported previous chlorpyrifos poisoning and 2 tests for the 18 men with a susceptible genotype. We also found no widespread pattern of effects associated with exposure in most other tests. However, there were exceptions to this generally negative pattern. The exposed subjects did not perform as well as the nonexposed subjects on pegboard turning and postural sway tests. Most markedly, the exposed subjects consistently reported more current psychologic and physical symptoms than the nonexposed subjects. The differences between exposed and nonexposed subjects for self-reported symptoms could have been a true effect of exposure. One prior study of chlorpyrifos-exposed subjects in a manufacturing setting also found significant increases in such ill-defined conditions (11) , and one study of men poisoned by chlorpyrifos (in combination with other organophosphates) found more severe self-reported mood states than a nonpoisoned comparison group (9) . It is possible that there was a systematic bias of applicators to overreport their symptoms, but we have no evidence to support such a bias. The applicators did not, in general, appear to complain about chlorpyrifos during the testing sessions.
The differences in symptoms were more marked for former rather than current applicators, suggesting a long-term effect. However, these differences were generally not more apparent for those with longer exposure to chlorpyrifos. Future studies should consider the temporal sequence of exposure and any self-reported symptoms; we lacked data on this question because our questionnaire was limited to current symptoms.
We observed a pattern of worse performance on several tests (sway, pinprick sensitivity, self-reported physical and mental symptoms, two neurobehavioral tests) by the participants (n = 8) who reported chloripyrifos poisoning as compared with other applicators. The data on poisoning are limited because of their self-reported nature; these poisonings represent a past acute exposure accompanied by self-reported symptoms (only one of the eight men who reported poisoning sought medical treatment). Similar findings for self-reported negative mood scales was also reported in a previous study (9) for the subgroup with chlorpyrifos poisoning. Our findings for the eight men who reported chlorpyrifos poisoning suggest that further study of the delayed effects of chlorpyrifos poisoning are warranted.
Applicators with a paraoxonase genotype expected to increase sensitivity to the effects of organophosphates (n = 18) showed few positive effects, with the exception of two tests on the clinical examination.
We studied applicators with a relatively short duration of exposure (2 years) to chlorpyrifos, possibly limiting our ability to observe exposure effects. Furthermore, it is possible that exposures were not sufficiently high for an exposure effect to be observed. However, 18% of the exposed subjects had more than 4 years of exposure, and their exposure levels (as indicated by urinary TCP) were two orders of magnitude greater than background levels in the U.S. population (4) .
In summary, in this cross-sectional study of workers exposed to chlorpyrifos, we found few exposure-related effects for most tests, including a clinical examination. However, the exposed subjects did not perform as well as the nonexposed subjects on pegboard turning tests and some postural sway tests. Furthermore, exposed subjects reported more symptoms than nonexposed subjects; this is a cause for concern because previous studies (9,11) lend some support to this finding. There was some suggestion of a pattern of delayed effects for subjects with a past history of poisoning, which is also supported by some previous reports of men poisoned by organophosphates (9, 39, 40) . Although this was a relatively large study based on a welldefined target population, the workers we studied may not be representative of all exposed workers, and caution should be exercised in generalizing our results.
